Zhang Li, Hao Chunfang, Dong Guolei, Tong Zhongsheng
Department of Breast Oncology, Tianjin Medical University Cancer Institute and Hospital, Cancer Research Key Laboratory of Education Ministry, Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin, China.
Breast Care (Basel). 2012 Feb;7(1):13-17. doi: 10.1159/000336539. Epub 2012 Feb 13.
The purpose of this study was to investigate the clinicopathological features and analyze the prognostic factors of triple-negative breast cancer (TNBC). PATIENTS AND METHODS: The clinical data of 1,788 breast cancer patients was collected and analyzed. The Kaplan-Meier method was used to estimate survival. Multivariate analysis of the prognostic factors for survival was performed using the Cox regression model. RESULTS: Patients with TNBC exhibited characteristics significantly differing from those with non-TNBC. There was a higher proportion of patients with age < 35 years, stage III disease, tumor size > 5 cm, lymph node positivity, and histological grade 3. The 5-year disease-free survival (DFS) rates of TNBC and non-TNBC patients were 75.7 and 79.6%, respectively (p < 0.05). 5-year overall survival (OS) was 86.6 and 93.5%, respectively (p < 0.05). In multivariate Cox regression analysis, the independent prognostic factors for shorter DFS were age < 35 years (hazard ratio (HR) 2.105), positive lymph nodes (HR 7.039), histological grade 3 (HR 1.841), and for shorter OS positive lymph nodes (HR 4.626). CONCLUSION: The proportion of TNBC in breast cancer in China is higher than in other areas. TNBC is correlated with younger age, larger tumor size, positive lymph nodes, higher clinical stage and histological grade, and lower DFS and OS, which is consistent with previous reports.
本研究旨在探讨三阴性乳腺癌(TNBC)的临床病理特征并分析其预后因素。
收集并分析1788例乳腺癌患者的临床资料。采用Kaplan-Meier法估计生存率。使用Cox回归模型对生存预后因素进行多变量分析。
TNBC患者表现出与非TNBC患者显著不同的特征。年龄<35岁、Ⅲ期疾病、肿瘤大小>5cm、淋巴结阳性和组织学3级的患者比例更高。TNBC和非TNBC患者的5年无病生存率(DFS)分别为75.7%和79.6%(p<0.05)。5年总生存率(OS)分别为86.6%和93.5%(p<0.05)。在多变量Cox回归分析中,DFS较短的独立预后因素为年龄<35岁(风险比(HR)2.105)、淋巴结阳性(HR 7.039)、组织学3级(HR 1.841),OS较短的独立预后因素为淋巴结阳性(HR 4.626)。
中国乳腺癌中TNBC的比例高于其他地区。TNBC与较年轻的年龄、较大的肿瘤大小、淋巴结阳性、较高的临床分期和组织学分级相关,且DFS和OS较低,这与先前的报道一致。